Clinical Trials List
2020-09-01 - 2026-12-31
Phase III
Recruiting4
-
Trial Applicant
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- Jiun-I Lai Division of Hematology & Oncology
- 翁敬堯 Division of Radiology
- 李瑩琦 Division of Radiology
- Ming-Huang Chen Division of Hematology & Oncology
- 張瀛月 Division of Radiology
- Sheng-Yu Chen Division of Hematology & Oncology
- Chueh-Chuan Yen Division of Hematology & Oncology
- 王彥博 Division of General Internal Medicine
- Yi-Ping Hung Division of Hematology & Oncology
- 陳盛裕 未分科
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- JHE-CYUAN GUO Division of Hematology & Oncology
- Kun-Huei Yeh Division of Hematology & Oncology
- 郭弘揚 Division of Hematology & Oncology
- Chia-Chi Lin Division of Hematology & Oncology
- TA-CHEN HUANG Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 黃泰霖 Division of Hematology & Oncology
- 陳彥豪 Division of Hematology & Oncology
- Tai-Jan Chiu Division of Hematology & Oncology
- 吳佳哲 Division of Hematology & Oncology
- Yu-Li Su Division of Hematology & Oncology
- 林偉哲 Division of Radiology
- 郭明濬 Division of Hematology & Oncology
- 賴香蘭 Division of Hematology & Oncology
- 劉建廷 Division of Hematology & Oncology
- 湯禹舜 Division of Radiology
- 黃詩喻 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Yau-Lin Tseng Division of Thoracic Surgery
- Shang-Yin Wu Division of Hematology & Oncology
- Wei-Lun Chang Division of General Internal Medicine
- 劉奕廷 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
21-42 participants
-
Global
450 participants
